CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice

Plasmid DNA (pDNA) represents a promising “genetic vaccine platform” capable of overcoming major histocompatibility complex barriers. We previously demonstrated that low-to-moderate doses of mucosae-associated epithelial chemokine (MEC or CCL28) as an immunomodulatory adjuvant can trigger effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Hu, Kai, Fu, Ming, Deng, Xu, Guan, Xinmeng, Luo, Sukun, Zhang, Mudan, Liu, Yalan, Hu, Qinxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415327/
https://www.ncbi.nlm.nih.gov/pubmed/36016177
http://dx.doi.org/10.3390/vaccines10081291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415327/
https://www.ncbi.nlm.nih.gov/pubmed/36016177
http://dx.doi.org/10.3390/vaccines10081291

Ejemplares similares